Glucagon‐like peptide‐1 receptor agonist treatment associated weight fluctuation and influencing factors in patients with overweight or obesityJingxuan Wang, Linong Ji, Tingyang Wei et al.|Diabetes Obesity and Metabolism|2025Cited by 2
PCSK9 Inhibitor and Potential Decreased Risk of Neoplasms, Especially in Females: A Meta-AnalysisTingyang Wei, Linong Ji, Fang Lv et al.|Pharmaceuticals|2025Cited by 1